Desk›Fast Moving Consumer Goods› Indo Us Bio-Tech Ltd
Indo Us Bio-Tech Ltd
BSE 541304 · NSE INDOUS · ISIN INE250Z01010 · Group B · Active
Fast Moving Consumer Goods › Fast Moving Consumer Goods › Agricultural Food & other Products › Other Agricultural Products
₹82.50
+0.61%
BSE close, 28 August 2026
₹165.43 cr
2.0 cr shares · Micro cap
₹49.34 cr
as published
14.4× · 2.35×
EPS ₹5.71 · BV ₹35.11
110.44 / 13.12
₹ cr, as filed
9
2 selected · 22%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -48.1% |
|---|---|
| Against 52-week low | +9.0% |
| Day change | +0.61% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹5.71 |
|---|---|
| Price / earnings | 14.45× |
| Price / book | 2.35× |
| Book value — derived, price ÷ P/B | ₹35.11 |
| Return on equity | 16.31% |
| Operating margin | 12.38% |
| Net margin | 9.21% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 16.26%
- ROE as published
- 16.31%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 32.99 | 3.04 | 1.51 | 12.38% | 9.21% |
| Mar-26 · Q | 26.03 | 1.97 | 0.98 | 12.49% | 7.58% |
| FY25-26 | 110.44 | 13.12 | 6.54 | 15.45% | 11.88% |
Quarter on quarter
- Revenue, quarter on quarter
- +26.7%
- Net profit, quarter on quarter
- +54.3%
- Operating margin, quarter on quarter
- -11 bps
Disclosure profile 9 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Results | 1 |
| Selected sub-total | 2 |
| Procedural | |
| AGM / EGM | 2 |
| Postal Ballot | 2 |
| Board Meeting | 1 |
| Newspaper Publication | 1 |
| Trading Window | 1 |
| Procedural sub-total | 7 |
| Total | 9 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
9 filings · 2 selected · busiest 2026-08-05 and 2026-08-12
Filing rhythm · the twelve most recent
2026-08-042026-10-02
SelectedProcedural
Filings
9 in the window · 9 earlier on record
-
2 October 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Voting Results and Scrutinizer's Report for passing resolutions through remote e voting in 22nd AGM of the Company
AGM/EGM / AGM View filing →
-
30 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to regulation 30 of SEBI LODR Regulations, we here by enclose a gist of proceedings of 22nd AGM held on Wednesday 30th September, 2026. Request you to take the same on the record ....
AGM/EGM / AGM View filing →
-
28 September 2026 ·
Closure of Trading Window
Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
13 August 2026 ·
Newspaper Publication
Submitting Newspaper Advertisement relating to the Unaudited Quarterly Standalone Financial Results for the quarter ended on 30th June, 2026.
Company Update / Newspaper Publication View filing →
-
12 August 2026 ·
Results- Financial Results For June 30, 2026
Financial Results for the quarter ended on 30-06-2026
Result / Financial Results View filing →
-
12 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held On August 12, 2026, Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
Pursuant to the Regulation 30 of the SEBI (Listing Obligation and Disclosures Requirements) Regulation, 2015, we wish to inform you that the Board of Directors of the Company at their meeting ....
Board Meeting / Outcome of Board Meeting View filing →
-
5 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Proceedings
AGM/EGM / Postal Ballot View filing →
-
5 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Postal Ballot Results by remove e voting process and Scrutinizer's Report.
AGM/EGM / Postal Ballot View filing →
-
4 August 2026 ·
541304 - Board Meeting Intimation for (A) The Unaudited Financial Results For The Quarter Ended On June 30, 2026, Pursuant To Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015; (B) Other Corporate Matters.
Indo Us Bio-Tech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve (a) The Unaudited Financial ....
Board Meeting / Board Meeting View filing →
RSS feed for Indo Us Bio-Tech Ltd · the 50 most recent filings